Global Spinal Muscular Atrophy Treatment Market Insights, Forecast to 2028

  • Report ID:239184
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 76
                              
Spinal Muscular Atrophy Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Spinal Muscular Atrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Oral Intrathecal Segment by Application SMA Type 1 SMA Type 2 SMA Type 3 SMA Type 4 By Company Biogen Roche Avexis By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Spinal Muscular Atrophy Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Oral 1.2.3 Intrathecal 1.3 Market by Application 1.3.1 Global Spinal Muscular Atrophy Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 SMA Type 1 1.3.3 SMA Type 2 1.3.4 SMA Type 3 1.3.5 SMA Type 4 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Spinal Muscular Atrophy Treatment Market Perspective (2017-2028) 2.2 Spinal Muscular Atrophy Treatment Growth Trends by Region 2.2.1 Spinal Muscular Atrophy Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Spinal Muscular Atrophy Treatment Historic Market Size by Region (2017-2022) 2.2.3 Spinal Muscular Atrophy Treatment Forecasted Market Size by Region (2023-2028) 2.3 Spinal Muscular Atrophy Treatment Market Dynamics 2.3.1 Spinal Muscular Atrophy Treatment Industry Trends 2.3.2 Spinal Muscular Atrophy Treatment Market Drivers 2.3.3 Spinal Muscular Atrophy Treatment Market Challenges 2.3.4 Spinal Muscular Atrophy Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Spinal Muscular Atrophy Treatment Players by Revenue 3.1.1 Global Top Spinal Muscular Atrophy Treatment Players by Revenue (2017-2022) 3.1.2 Global Spinal Muscular Atrophy Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Spinal Muscular Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Spinal Muscular Atrophy Treatment Revenue 3.4 Global Spinal Muscular Atrophy Treatment Market Concentration Ratio 3.4.1 Global Spinal Muscular Atrophy Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Treatment Revenue in 2021 3.5 Spinal Muscular Atrophy Treatment Key Players Head office and Area Served 3.6 Key Players Spinal Muscular Atrophy Treatment Product Solution and Service 3.7 Date of Enter into Spinal Muscular Atrophy Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Spinal Muscular Atrophy Treatment Breakdown Data by Type 4.1 Global Spinal Muscular Atrophy Treatment Historic Market Size by Type (2017-2022) 4.2 Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Type (2023-2028) 5 Spinal Muscular Atrophy Treatment Breakdown Data by Application 5.1 Global Spinal Muscular Atrophy Treatment Historic Market Size by Application (2017-2022) 5.2 Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Spinal Muscular Atrophy Treatment Market Size (2017-2028) 6.2 North America Spinal Muscular Atrophy Treatment Market Size by Type 6.2.1 North America Spinal Muscular Atrophy Treatment Market Size by Type (2017-2022) 6.2.2 North America Spinal Muscular Atrophy Treatment Market Size by Type (2023-2028) 6.2.3 North America Spinal Muscular Atrophy Treatment Market Share by Type (2017-2028) 6.3 North America Spinal Muscular Atrophy Treatment Market Size by Application 6.3.1 North America Spinal Muscular Atrophy Treatment Market Size by Application (2017-2022) 6.3.2 North America Spinal Muscular Atrophy Treatment Market Size by Application (2023-2028) 6.3.3 North America Spinal Muscular Atrophy Treatment Market Share by Application (2017-2028) 6.4 North America Spinal Muscular Atrophy Treatment Market Size by Country 6.4.1 North America Spinal Muscular Atrophy Treatment Market Size by Country (2017-2022) 6.4.2 North America Spinal Muscular Atrophy Treatment Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Spinal Muscular Atrophy Treatment Market Size (2017-2028) 7.2 Europe Spinal Muscular Atrophy Treatment Market Size by Type 7.2.1 Europe Spinal Muscular Atrophy Treatment Market Size by Type (2017-2022) 7.2.2 Europe Spinal Muscular Atrophy Treatment Market Size by Type (2023-2028) 7.2.3 Europe Spinal Muscular Atrophy Treatment Market Share by Type (2017-2028) 7.3 Europe Spinal Muscular Atrophy Treatment Market Size by Application 7.3.1 Europe Spinal Muscular Atrophy Treatment Market Size by Application (2017-2022) 7.3.2 Europe Spinal Muscular Atrophy Treatment Market Size by Application (2023-2028) 7.3.3 Europe Spinal Muscular Atrophy Treatment Market Share by Application (2017-2028) 7.4 Europe Spinal Muscular Atrophy Treatment Market Size by Country 7.4.1 Europe Spinal Muscular Atrophy Treatment Market Size by Country (2017-2022) 7.4.2 Europe Spinal Muscular Atrophy Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size (2017-2028) 8.2 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Type 8.2.1 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Spinal Muscular Atrophy Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Application 8.3.1 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Spinal Muscular Atrophy Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region 8.4.1 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Spinal Muscular Atrophy Treatment Market Size (2017-2028) 9.2 Latin America Spinal Muscular Atrophy Treatment Market Size by Type 9.2.1 Latin America Spinal Muscular Atrophy Treatment Market Size by Type (2017-2022) 9.2.2 Latin America Spinal Muscular Atrophy Treatment Market Size by Type (2023-2028) 9.2.3 Latin America Spinal Muscular Atrophy Treatment Market Share by Type (2017-2028) 9.3 Latin America Spinal Muscular Atrophy Treatment Market Size by Application 9.3.1 Latin America Spinal Muscular Atrophy Treatment Market Size by Application (2017-2022) 9.3.2 Latin America Spinal Muscular Atrophy Treatment Market Size by Application (2023-2028) 9.3.3 Latin America Spinal Muscular Atrophy Treatment Market Share by Application (2017-2028) 9.4 Latin America Spinal Muscular Atrophy Treatment Market Size by Country 9.4.1 Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2017-2022) 9.4.2 Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size (2017-2028) 10.2 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Type 10.2.1 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Spinal Muscular Atrophy Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Application 10.3.1 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Spinal Muscular Atrophy Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country 10.4.1 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Biogen 11.1.1 Biogen Company Details 11.1.2 Biogen Business Overview 11.1.3 Biogen Spinal Muscular Atrophy Treatment Introduction 11.1.4 Biogen Revenue in Spinal Muscular Atrophy Treatment Business (2017-2022) 11.1.5 Biogen Recent Developments 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Spinal Muscular Atrophy Treatment Introduction 11.2.4 Roche Revenue in Spinal Muscular Atrophy Treatment Business (2017-2022) 11.2.5 Roche Recent Developments 11.3 Avexis 11.3.1 Avexis Company Details 11.3.2 Avexis Business Overview 11.3.3 Avexis Spinal Muscular Atrophy Treatment Introduction 11.3.4 Avexis Revenue in Spinal Muscular Atrophy Treatment Business (2017-2022) 11.3.5 Avexis Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Spinal Muscular Atrophy Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Oral Table 3. Key Players of Intrathecal Table 4. Global Spinal Muscular Atrophy Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Spinal Muscular Atrophy Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Spinal Muscular Atrophy Treatment Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Spinal Muscular Atrophy Treatment Market Share by Region (2017-2022) Table 8. Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Spinal Muscular Atrophy Treatment Market Share by Region (2023-2028) Table 10. Spinal Muscular Atrophy Treatment Market Trends Table 11. Spinal Muscular Atrophy Treatment Market Drivers Table 12. Spinal Muscular Atrophy Treatment Market Challenges Table 13. Spinal Muscular Atrophy Treatment Market Restraints Table 14. Global Spinal Muscular Atrophy Treatment Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Spinal Muscular Atrophy Treatment Revenue Share by Players (2017-2022) Table 16. Global Top Spinal Muscular Atrophy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Treatment as of 2021) Table 17. Ranking of Global Top Spinal Muscular Atrophy Treatment Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Treatment Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Spinal Muscular Atrophy Treatment Product Solution and Service Table 21. Date of Enter into Spinal Muscular Atrophy Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Spinal Muscular Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type (2017-2022) Table 25. Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type (2023-2028) Table 27. Global Spinal Muscular Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Spinal Muscular Atrophy Treatment Revenue Share by Application (2017-2022) Table 29. Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Spinal Muscular Atrophy Treatment Revenue Share by Application (2023-2028) Table 31. North America Spinal Muscular Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Spinal Muscular Atrophy Treatment Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Spinal Muscular Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Spinal Muscular Atrophy Treatment Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Spinal Muscular Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Spinal Muscular Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Spinal Muscular Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Spinal Muscular Atrophy Treatment Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Spinal Muscular Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Spinal Muscular Atrophy Treatment Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Spinal Muscular Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Spinal Muscular Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Spinal Muscular Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Spinal Muscular Atrophy Treatment Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Spinal Muscular Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Spinal Muscular Atrophy Treatment Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Spinal Muscular Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Spinal Muscular Atrophy Treatment Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Spinal Muscular Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Spinal Muscular Atrophy Treatment Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Spinal Muscular Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Spinal Muscular Atrophy Treatment Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Spinal Muscular Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Spinal Muscular Atrophy Treatment Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Spinal Muscular Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Spinal Muscular Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million) Table 61. Biogen Company Details Table 62. Biogen Business Overview Table 63. Biogen Spinal Muscular Atrophy Treatment Product Table 64. Biogen Revenue in Spinal Muscular Atrophy Treatment Business (2017-2022) & (US$ Million) Table 65. Biogen Recent Developments Table 66. Roche Company Details Table 67. Roche Business Overview Table 68. Roche Spinal Muscular Atrophy Treatment Product Table 69. Roche Revenue in Spinal Muscular Atrophy Treatment Business (2017-2022) & (US$ Million) Table 70. Roche Recent Developments Table 71. Avexis Company Details Table 72. Avexis Business Overview Table 73. Avexis Spinal Muscular Atrophy Treatment Product Table 74. Avexis Revenue in Spinal Muscular Atrophy Treatment Business (2017-2022) & (US$ Million) Table 75. Avexis Recent Developments Table 76. Research Programs/Design for This Report Table 77. Key Data Information from Secondary Sources Table 78. Key Data Information from Primary Sources List of Figures Figure 1. Global Spinal Muscular Atrophy Treatment Market Share by Type: 2021 VS 2028 Figure 2. Oral Features Figure 3. Intrathecal Features Figure 4. Global Spinal Muscular Atrophy Treatment Market Share by Application: 2021 VS 2028 Figure 5. SMA Type 1 Case Studies Figure 6. SMA Type 2 Case Studies Figure 7. SMA Type 3 Case Studies Figure 8. SMA Type 4 Case Studies Figure 9. Spinal Muscular Atrophy Treatment Report Years Considered Figure 10. Global Spinal Muscular Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Spinal Muscular Atrophy Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Spinal Muscular Atrophy Treatment Market Share by Region: 2021 VS 2028 Figure 13. Global Spinal Muscular Atrophy Treatment Market Share by Players in 2021 Figure 14. Global Top Spinal Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Treatment as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Treatment Revenue in 2021 Figure 16. North America Spinal Muscular Atrophy Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 17. North America Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2017-2028) Figure 18. North America Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2017-2028) Figure 19. North America Spinal Muscular Atrophy Treatment Market Size Share by Country (2017-2028) Figure 20. United States Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Spinal Muscular Atrophy Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 23. Europe Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2017-2028) Figure 24. Europe Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2017-2028) Figure 25. Europe Spinal Muscular Atrophy Treatment Market Size Share by Country (2017-2028) Figure 26. Germany Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. France Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. U.K. Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Italy Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Russia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Nordic Countries Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 33. Asia Pacific Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2017-2028) Figure 34. Asia Pacific Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2017-2028) Figure 35. Asia Pacific Spinal Muscular Atrophy Treatment Market Size Share by Region (2017-2028) Figure 36. China Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Japan Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. South Korea Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Southeast Asia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. India Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Australia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 42. Latin America Spinal Muscular Atrophy Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 43. Latin America Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2017-2028) Figure 44. Latin America Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2017-2028) Figure 45. Latin America Spinal Muscular Atrophy Treatment Market Size Share by Country (2017-2028) Figure 46. Mexico Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Brazil Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 49. Middle East and Africa Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2017-2028) Figure 50. Middle East and Africa Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2017-2028) Figure 51. Middle East and Africa Spinal Muscular Atrophy Treatment Market Size Share by Country (2017-2028) Figure 52. Turkey Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Saudi Arabia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. UAE Spinal Muscular Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Biogen Revenue Growth Rate in Spinal Muscular Atrophy Treatment Business (2017-2022) Figure 56. Roche Revenue Growth Rate in Spinal Muscular Atrophy Treatment Business (2017-2022) Figure 57. Avexis Revenue Growth Rate in Spinal Muscular Atrophy Treatment Business (2017-2022) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.